Characterization of chronic low-level proteasome inhibition on neural homeostasis

Journal of Neurochemistry

Volumn 86, Issue 2, 2003, Pages 489-497

  Ding, Qunxing ^a   Dimayuga, Edgardo ^a   Martin, Sarah ^a   Bruce Keller, Annadora J ^a   Nukala, Vidya ^a   Cuervo, Ana Maria ^b   Keller, Jeffrey N ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Autophagy; Lysosome; Oxidative stress; Proteasome; Protein aggregation; Protein oxidation

Indexed keywords

PROTEASOME; PROTEASOME INHIBITOR;

ARTICLE; AUTOPHAGY; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL NECROSIS; NERVOUS SYSTEM; NEUROBLASTOMA CELL; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SOLUBILITY; STATISTICAL SIGNIFICANCE;

AUTOPHAGY; BLOOD PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CLONE CELLS; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; HOMEOSTASIS; HUMANS; LEUPEPTINS; LYSOSOMES; MULTIENZYME COMPLEXES; NEURONS; OXIDANTS; OXIDATION-REDUCTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; SOLUBILITY; TIME; UBIQUITIN;

EID: 0038493550     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01885.x     Document Type: Article

References (46)

1. Aksenova M., Butterfield D. A., Zhang S. X., Underwood M. and Geddes J. W. (2002) Increased protein oxidation and decreased creatine kinase BB expression and activity after spinal cord contusion injury. J. Neurotrauma 19, 491-502.
2. Anglade P., Vyas S., Javoy-Agid F., Herrero M. T., Michel P. P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E. C. and Agid Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25-31.
3. Azuma-Hara M., Taniura H., Uetsuki T., Niinobe M. and Yoshikawa K. (1999) Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells. Exp. Cell Res. 251, 442-451.
4. Bahr B. and Bendiske J. (2002) The neuropathogenic contribution of lysosomal dysfunction. J. Neurochem. 83, 481-489.
5. Blommaart E. F., Luiken J. J. and Meijer A. J. (1997) Autophagic proteolysis: control and specificity. Histochem. J. 29, 365-385.
6. Boutillier A. L., Kienlen-Campard P. and Loeffler J. P. (1999) Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway. Eur. J. Neurosci. 11, 441-448.
7. Campbell B. C., Li Q. X., Culvenor J. G., Jakala P., Cappai R., Beyreuther K., Masters C. L. and McLean C. A. (2000) Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies. Neurobiol Dis. 7, 192-200.
8. Cataldo A. M., Hamilton D. J., Barnett J. L., Paskevich P. A. and Nixon R. A. (1996) Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16, 186-199.
9. Cuervo A. and Dice J. (1996) A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273, 501-503.
10. Davies K. J. (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83, 301-310.
11. Ding Q. and Keller J. N. (2001a) Proteasomes and proteasome inhibition in the central nervous system. Free Radic. Biol. Med. 31, 574-584.
12. Ding Q. and Keller J. N. (2001b) Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J. Neurochem. 77, 1010-1017.
13. Ding Q., Lewis J. J., Strum K. M., Dimayuga E., Bruce-Keller A. J., Dunn J. C. and Keller J. N. (2002) Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J. Biol. Chem. 277, 13935-13942.
14. Glickman M. H. and Ciechanover A. (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev 82, 373-428.
15. Goldberg A. L., Akopian T. N., Kisselev A. F., Lee D. H. and Rohrwild M. (1997) New insights into the mechanisms and importance of the proteasome in intracellular protein degradation. Biol. Chem. 378, 131-140.
16. Holen I., Stromhaug P., Gordon P., Fengrud M., Berg T. and Seglen P. (1995) Inhibition of autophagy and multiple steps in asialoglycoprotein endocytosis by inhibitors of protein kinases (tyrphostins). J. Biol. Chem. 270, 12823-12831.
17. Holtsberg F. W., Steiner M. R., Bruce-Keller A. J., Keller J. N., Mattson M. P., Moyers J. C. and Steiner S. M. (1998) Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells. J. Neurosci. Res. 53, 685-696.
18. Hyun D. H., Lee M. H., Halliwell B. and Jenner P. (2002) Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration? J. Neurochem. 83, 360-370.
19. Kawarabayashi T., Younkin L. H., Saido T. C., Shoji M., Ashe K. H. and Younkin S. G. (2001) Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21, 372-381.
20. Keller J. N. and Markesbery W. R. (2000) Proteasome inhibition results in increased poly-ADP-ribosylation: implications for neuron death. J. Neurosci. Res. 61, 436-442.
21. Keller J. N., Kindy M. S., Holtsberg F. W., St Clair D. K., Yen H. C., Germeyer A., Steiner S. M., Bruce-Keller A. J., Hutchins J. B. and Mattson M. P. (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18, 687-697.
22. Keller J. N., Hanni K. B. and Markesbery W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439.
23. Kim J. and Klionsky D. J. (2000) Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells. Annu. Rev. Biochem. 69, 303-342.
24. Kopito R. R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524-530.
25. Kopito R. R. and Sitia R. (2000) Aggresomes and Russell bodies. Symptoms of cellular indigestion? EMBO Rep. 1, 225-231.
26. Larsen K. E. and Sulzer D. (2002) Autophagy in neurons: a review. Histol. Histopathol. 17, 897-908.
27. Larsen K. E., Fon E. A., Hastings T. G., Edwards R. H. and Sulzer D. (2002) Methamphetamine-induced degeneration of dopaminergic neurons induces autophagy and upregulation of dopamine synthesis. J. Neurosci. 22, 8951-8960.
28. Lauderback C. M., Hackett J. M., Keller J. N., Varadarajan S., Szweda L., Kindy M., Markesbery W. R. and Butterfield D. A. (2001) Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta (1-40): implications for Alzheimer's disease. Biochemistry 40, 2548-2554.
29. Lee M. H., Hyun D. H., Jenner P. and Halliwell B. (2001) Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 78, 32-41.
30. Lopez-Salon M., Morelli L., Castano E. M., Soto E. F. and Pasquini J. M. (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302-310.
31. Martin A., Joseph J. A. and Cuervo A. M. (2003) Stimulatory effect of vitamin C on autophagy in glial cells. J. Neurochem. 82, 538-549.
32. Massa S. M., Swanson R. A. and Sharp F. R. (1996) The stress gene response in brain. Cerebrovasc. Brain Metab. Rev. 8, 95-158.
33. McNaught K. S. and Jenner P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191-194.
34. McNaught K. S., Olanow C. W. and Halliwell B. (2001) Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2, 589-594.
35. McNaught K. S., Bjorklund L. M., Belizaire R., Isacson O., Jenner P. and Olanow C. W. (2002) Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. Neuroreport 13, 1437-1441.
36. McNaught K. S., Belzizaire R., Isacson O., Jenner P. and Olanow C. W. (2003) Altered proteasome function in sporadic Parksinon's disease. Exp. Neurol. 179, 38-46.
37. Nagao Y., Ishiguro H. and Nukina N. (2000) DMSO and glycerol reduce bacterial death induced by expression of truncated N-terminal huntingtin with expanded polyglutamine tracts. Biochim. Biophys. Acta 1502, 247-256.
38. Naujokat C. and Hoffmann S. (2002) Role and function of the 26S proteasome in proliferation and apoptosis. Lab. Invest. 82, 965-980.
39. Nixon R. A., Cataldo A. M. and Mathews P. M. (2000) The endosomal-lysosomal system of neurons in AD pathogenesis: a review. Neurochem. Res. 25, 1161-1172.
40. Pasquini L. A., Besio-Moreno M., Adamo A. M., Pasquini J. M. and Soto E. F. (2000) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J. Neurosci. Res. 59, 601-611.
41. Qiu J. H., Asai A., Chi S., Saito N., Hamada H. and Kirino T. (2000) Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20, 259-265.
42. Rideout H. J., Larsen K. E., Sulzer D. and Stefanis L. (2001) Proteasome inhibition leads to formation of ubiquitin alpha-synuclein-immunoreactive inclusions in PC12 cells. J. Neurochem. 78, 899-908.
43. Rideout H. J., Wang Q., Park D. S. and Stephanis L. (2003) Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasome inhibition. J. Neurosci. 23, 1237-1245.
44. Shringarpure R., Grune T., Mehlhase J. and Davies K. J. (2003) Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J. Biol. Chem. 278, 311-318.
45. Taylor J. P., Tanaka F., Robitschek J., Sandoval C. M., Taye A., Markovic-Plese S. and Fischbeck K. H. (2003) Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12, 749-757.
46. Ulrich H. D. (2002) Natural substrates of the proteasome and their recognition by the ubiquitin system. Curr. Top. Microbiol. Immunol. 268, 137-174.